Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review

Serhan CN, Chiang N, Dyke Van TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349–361 Guzik T, Mangalat D, Korbut R (2006) Adipocytokines—novel link between inflammation and vascular function? J Physiol Pharmacol 57(4):505–528 McGeer EG, Klegeris A, McGeer PL (2005) Inflammation, the complement system and the diseases of aging. Neurobiol Aging 26:94–97 Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49:1603–1616 Flohé L, Brigelius-Flohé R, Saliou C, Traber M, Packer L (1997) Redox regulation of NF-κB activation. Free Radical Biol Med 6:1115–1126 Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE (2007) Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 147(2):061127015327006 Keane MP, Strieter RM (2000) Chemokine signalling in inflammation. Crit Care Med 28:13–26 Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Immunol 7:678–689 Muller WA (2003) Leukocyte–endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24:327–334 Wang HB, Wang JT, Zhang L, Geng ZH, Xu WL, Xu T, Huo Y, Zhu X, Plow ED, Chen M, Geng JG (2007) P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 8:882–892 Mukaida N, Matsumoto T, Yokoi K, Harada A, Matsushima K (1998) Inhibition of neutrophil-mediated acute inflammatory injury by an antibody against interleukin-8 (IL-8). Inflamm Res 47:151–157 Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851–856 Daniel T, Thobe BM, Chaudhary IH, Choudhary MA, Hubbard WJ, Schwacha MG (2007) Regulation of the postburn wound inflammatory response by γδ T-cells. Shock 28:278–283 Mannaioni PF, Bello MG, Masini E (1997) Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 46:4–18 Andra J, Gutsmann T, Garidel P, Brandenburg K (2006) Mechanisms of endotoxin neutralization by synthetic cationic compounds. J Endotoxin Res 12:261–277 Grimble R (1998) Nutritional modulation of cytokine biology. Nutrition 14:634–640 Serhan CN, Savill J (2005) Resolution of inflammation: the beginnning programs the end. Nat Immunol 6:1191–1197 Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612–619 Van Dyke TE, Serhan CN (2003) Resolution of Inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 82:82–90 Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbeham B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE (2003) Reduced inflammation and tissuw damage in transgenic rabbits overexpressing 15-Lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171:6856–6865 Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN (2005) Molecular circuits of rsolution: formation and actions of resolvins and protectins. J Immunol 174:4345–4355 Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C (1996) In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol 157:2577–2585 Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD (1997) The codependence of angiogenesis and chronic inflammation. FASEB J 11:457–465 Yamamoto T (2008) Molecular mechanism of monocyte predominant inffilteration in chronic inflammation: mediation by a noval monocyte chemotactic factor, s19 ribosomal protein dimer. Pathol Int 50:863–871 Limuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG (2003) Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530–1537 Bonniaud P, Margetts P, Ask K, Flander K, Gauldie J, Kolb M (2005) TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol 175:5390–5395 Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumor-associated macrophages are a distinct M2 polarized population promoting tumor progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727 Decologne N, Kolb M, Margetts PJ, Menetrier F, Artur Y, Garrido C, Gauldie J, Camus P, Bonniaud P (2007) TGF-β1 induces progressive pleural scarring and subpleural fibrosis. J Immunol 179:6043–6051 Marin V, Julian AM, Gres S, Boulay V, Bongrand P, Farnarier C, Kaplanski G (2001) The IL-6-Soluble IL-6Rα Autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin. J Inflamm 167:3435–3442 Conti P, DiGioacchino M (2001) MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy and Asthma Proceedings. 22:133–137 Karin M, Lawrence T, Nizet V (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124:823–835 Batista ML, Santos RVT, Cunha LM, Mattos K, Oliveira EM, Costa Seelaender MCL, Rosa LFBP (2006) Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure. Cytokine 34:284–290 Andrea L, Jorge L, Antonio C (2009) Macrophage activation: classical vs. alternative. Macrophages Dendritic Cells 531:29–43 Corriveau CC, Madara PJ, Van Dervort AL, Tropea MM, Wesley RA, Danner RL (1998) Effects of nitric oxide on chemotaxis and endotoxin- induced interleukin-8 production in human neutrophils. J Infect Dis 177:116–126 Wang S, Yan L, Wesley RA, Danner RL (1997) Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J Biol Chem 272:5959–5969 Ding X, Hiraku Y, Ma N, Kato T, Saito K, Nagahama M, Semba R, Kuribayashi K, Kawanishi S (2005) Inducible nitric oxide synthase-dependant DNA damage in mouse model of inflammatory bowel disease. Cancer Sci 96(3):157–163 Hata AN, Breyer RM (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103:147–166 Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA (1996) Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin-6 in rat adjuvant arthritis. J Clin Investig 97:2672–2679 Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA, Isakson PC (1996) Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia and interleukin 6 production in vivo. J Exp Med 184:883–891 Mark BP, Gideon MH (2003) C-reactive protein: a critical update. J Clin Investig 111(12):1805–1812 Semple SJ (2006) C-reactive protein—biological functions, cardiovascular disease and physical exercise. SaJSM 18(1):24–28 Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115–126 Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L (2002) C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr Cartil 10:595–601 Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585–590 Simon HU, Haj-Yehia A, Levi-Schaffer F (2000) Role of reactive oxygen species (ROS) in the apoptosis induction. Apoptosis 5:415–418 Stief TW (2003) The physiology and pharmacology of singlet oxygen. Med Hypoth 60:567–572 Packer L, Weber SU, Rimbach G (2001) Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr 131(2):369S–373S Patil S, Jolly CI, Narayanan S (2000) free radical scavenging activity of acacia catechu and Rotula aquatica: implications in cancer therapy. Indian Drugs 40:328–332 D’Autreaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8(10):813–824 Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82(1):47–95 Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3:276–285 Mathy-Hartert M, Deby-Dupont GP, Reginster JY, Ayache N, Pujol JP, Henrotin YE (2002) Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes. Osteoarthr Cartil 10:547–555 Turpaev KT (2002) Reactive oxygen species and regulation of gene expression. Biochem (Mosc) 67:281–292 Gilroy DW, Colville-Nash PR, McMaster S, Sawatzky DA, Willoughby DA, Lawrence T (2003) Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J 17:2269–2271 Goossens V, Grooten J, De Vos K, Fiers W (1995) Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92:8115–8119 Ioanna K, Theodoros V, Angeliki X, Spyros Z, Andreas P, Charis R (2002) Production of interleukin-6 by skeletal myotubes role of reactive oxygen species. Am J Respir Cell Mol Biol 26:587–593 Edwina N, Vishva M (2013) Mitochondrial reactive oxygen species drive pro-inflammatory cytokine production. J Exp Med 208(3):417–420 Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim Y, Sack MN, Kastner DL, Siegel RM (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 208:519–533 Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M (2005) Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649–661 Chen F, Castranova V, Shi X, Demers LM (1999) New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45:7–17 Paul PT, Gary SF (2001) NF-κB: a key role in inflammatory diseases. Clin Invest. 107(1):7–11 Woo CH, Eom YW, Yoo MH, You HJ, Han HJ, Song WK, Yoo YJ, Chun JS, Kim JH (2000) Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 275:32357–32362 http://www.cancer.gov/cancertopics/what-is-cancer Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17–29 Moss SF, Blaser MJ (2005) Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2(2):90–97 Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, Ziche M (1998) Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90:587–596 Fukumura D, Kashiwagi S, Jain RK (2006) The role of nitric oxide in tumor progression. Nat Rev Cancer 6:521–534 Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T, Mor G (2008) Regulation of IKKbeta by miR-199a affects NF-κB activity in ovarian cancer cells. Oncogene 27:4712–4723 Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, Raymond N (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705–716 Wang W, Bergh A, Damber JE (2005) Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res 11:3250–3256 Zhao QT, Yue SQ, Cui Z, Wang Q, Cui X, Zhai HH, Zhang LH, Dou KF (2007) Potential involvement of the cyclooxygenase-2 in hepato cellular carcinoma-associated angiogenesis. Life Sci 80:484–492 Shi X, Chen G, Xing H, Weng D, Bai X, Ma D (2007) VEGF-C, VEGFR-3 and COX-2 enhances growth and metastasis of human cervical carcinoma cell lines in vitro. Oncol Rep 18:241–247 Apel K, Hirt H (2004) Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 55:373–399 Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31:1441–1444 Bergamini CM, Gambetti S, Dondi A, Cervellati C (2004) Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 10:1611–1626 Gulam W, Haseeb A (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 5:14 Bohr VA, Dianov GL (1999) Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 81:155–160 Marcus SC, Mark DE, Miral D, Joseph L (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB 17:1195–1214 Burdon RH, Alliangana D, Gill V (1999) Hydrogen peroxide in relation to proliferation and apoptosis in BHK-21 hamster fibroblasts. Free Radic Res 24:81–93 Lin MT, Yen ML, Lin CY, Kuo ML (2003) Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 64:1029–1036 Monaghan-Benson E, Burridge K (2009) The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 284:25602–25611 Doo JL, Sang WK (2013) Reactive oxygen species and tumor metastasis. Mol Cells 35:93–98 Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349:1436–1442 Blasi C (2008) The autoimmune origin of atherosclerosis. Atherosclerosis 201:17–32 Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22:361–403 Madamanchi NR, Runge M (2007) Mitochondrial dysfunction in atherosclerosis. Circ Res 100:460–473 Armitage JD, Vanniasinkam SH, Lindsey NJ (2004) The role of endothelial cell reactive antibodies in peripheral vascular disease. Autoimmun Rev 3:39–44 Hopper PL, Hooper JJ (2005) Loss of defense against stress: diabetes and heat shock proteins. Diabetes Technol Ther 7:204–208 Philip LH, Paul LH (2009) Inflammation, heat shock proteins, and type 2diabetes. Cell Stress Chaperones 14:113–115 Perschinka H, Mayr M, Millonig G, Mayerl C, Zee R, Morrison SG, Morrison RP, Xu Q, Wick G (2003) Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 23:1060–1065 Billack B, Heck DE, Mariano TM, Gardner CR, Sur R, Laskin DL, Laskin JD (2002) Induction of cyclooxygenase-2 by heat shock protein 60 in macrophages and endothelial cells. Cell Physiol 283:C1267–C1277 Kolodgie FD, Burke AP, Nakazawa G, Virmani R (2007) Is pathological intima thickening the key to understanding early plaque progression in human atherosclerosis disease? Arterioscler Thromb Vasc Biol 27:986–989 Skalen K, Gustafssom M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750–754 Leitinger N (2003) Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 14:421–430 Norata GD, Pirillo A, Pellegatta F, Inoue H, Catapano AL (2004) Native LDL and oxidized LDL modulate cyclooxygenase-2 expression in HUVEC through a p38-MAPK, NF-κB, CRE dependent pathway and affect PGE2 synthesis. Int J Mol Med 14:353–359 Chenevard R, Hurlimann D, Bechir M, Enseleit F, Spieker L, Hermann M, Riesen W, Gay S, Gay RE, Neidhart M, Michel B, Luscher TM, Noll G, Ruschitzka F (2003) Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 107:405–409 Wollenhaupt J, Zeidler H (1998) Undifferentiated arthritis and reactive arthritis. Curr Opin Rheumatol 10(4):306–313 Bridges PS (1992) Prehistoric arthritis in the Americas. Annu Rev Anthropol 21:67–91 Bonnet CS, Walsh DA (2005) Osteoarthritis, angiogenesis and inflammation. Rheumatology 44:7–16 Benito MJ, Veale DJ, Fitzgerald O, Berg WB, Bresnihan B (2005) Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64:1263–1267 Goldring MB, Berenbaum F (2004) The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 427:S37–S46 Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB (2006) STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 176(9):5652–5661 Gracia JA (2004) Interleukin-18 as a potential target in inflammatory arthritis. Clin Exp Immunol 136(3):402–404 Plater-Zyberk C, Joosten LA, Helsen MM, Koenders MI, Baeuerle PA, Van den Berg WB (2009) Combined blockade of GM-CSF and IL-17 pathways potently suppresses chronic destructive arthritis in a TNF-α independent mouse model. Ann Rheum Dis 68(5):721–728 Simmonds RE, Foxwell BM (2008) Signalling, inflammation and arthritis: NF–kappaB and its relevance to arthritis and inflammation. Rheumatology 47:584–590 Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Holers VM (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116(4):961–973 Sturnieks DL, Tiedemann A, Chapman K, Munro B, Murray SM, Lord SR (2004) Physiological risk factors for falls in older people with lower limb arthritis. J Rheumatol 31(11):2272–2279 Montecucco F, Mach F (2009) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 48:11–22 Moulton PJ, Hiran TS, Goldring MB, Hancock JT (1997) Detection of protein and mRNA of various components of the NADPH oxidase complex in an immortalized human chondrocyte line. Br J Rheumatol 36(5):522–529 Hitchon CA, Ei-Gabalawy HS (2004) Oxidation in rheumatoid arthritis. Arthritis Res Ther 6(6):265–278 Lloyds D, Davies EV, Williams BD, Hallett MB (1996) Tyrosine phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis. Br J Rheumatol 35(9):846–852 De Leo ME, Tranghese A, Passantino M, Mordente A, Lizzio MM, Galeotti T (2002) Manganese superoxide dismutase, glutathione peroxidase, and total radical trapping antioxidant capacity in active rheumatoid arthritis. J Rheumatol 29(10):2245–2246 Karatas F, Ozates I, Canatan H, Halifeoglu I, Karatepe H (2003) Antioxidant status and lipid peroxidation in patients with rheumatoid arthritis. Indian J Med Res 118:178–181 Center for Disease Control and Prevention (CDC) (2008) Diabetes data and trends. Number (in millions) of persons with diagnosed diabetes, United States, 1980–2005. http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm. Accessed February 9, 2008 Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053 Singh R, Shaw J, Zimmet P (2004) Epidemiology of child-hood type 2 diabetes in the developing world. Pediatr Diabetes 5:154–168 Treszl A, Szereday L, Doria A, King GL, Orban T (2004) Elevated C-reactive protein levels do not correspond to autoimmunity in type 1 diabetes. Diabetes Care 27:2769–2770 Devaraj S, Cheung AT, Jialal I, Steven CG, Danh N, Nicole G, Thomas A (2007) Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 56:2790–2796 Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD (2003) The EURODIAB Prospective Complications Study Group: vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes. Diabates Care 26:2165–2173 Chiung-Mei W, Chang-Hua C, Yao-Yi H, Chih-Chan L, Yen-Wen L, Wei-Chuan T (2010) Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients. Heart Vessels 25:386–391 Sarvetnick N, Shizuru J, Liggitt D, Martin L, McIntyre B, Gregory A, Parslow T, Stewart T (1990) Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 346:844–847 Varanasi V, Avanesyan L, Schumann MD, Chervonsky VA (2012) Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cells. Diabetes 61:2862–2870 Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334 Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455–461 Frank BH, James BM, Tricia YL, Nader R, Jo AE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53(3):693–700 Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9 Maritim C, Sanders RA, Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17(1):24–38 Ceriello A (2000) Oxidative stress and glycemic regulation. Metabolism 49(2, suppl 1):27–29 Ceriello A, Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816–823 Lindsey EP, Katarzyna AB, Polly AH, John AC, Hubert MT (2013) The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann NY Acad Sci 1281:16–35 West IC (2000) Radicals and oxidative stress in Diabetes. Diabet Med 17:171–180 Yong IC, Raymond ND (2007) NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58:239–252 Funk C, Fitzgerald G (2007) COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol 50:470–478 Hochberg MC (2002) New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis. Semin Arthritis Rheum 32:4–14 Tahereh T, Angelica MW, Jane MJ, Robert AF, Yashige K (2000) COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice. Biochem Biophys Res Commun 273:699–704